Scarica l'app Stockscreener
2.68
8.38%
-0.245
Dopo l'orario di chiusura:
2.68
Precedente Chiudi:
$2.925
Aprire:
$3.1853
Volume 24 ore:
129.28K
Relative Volume:
0.07
Capitalizzazione di mercato:
$4.28M
Reddito:
$6.59M
Utile/perdita netta:
$-18.12M
Rapporto P/E:
-0.2833
EPS:
-9.4605
Flusso di cassa netto:
$-11.45M
1 W Prestazione:
-21.41%
1M Prestazione:
-40.44%
6M Prestazione:
-31.29%
1 anno Prestazione:
-89.71%
Intervallo 1D:
$2.5801
$3.25
Intervallo di 1 settimana:
$2.5801
$3.67
Portata 52W:
$1.50
$44.10
Hcw Biologics Inc Stock (HCWB) Company Profile
Nome
Hcw Biologics Inc
Settore
Industria
Telefono
954-842-2024
Indirizzo
2929 N COMMERCE PKWY, MIRAMAR
Compare HCWB vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
2.68 | 5.02M | 6.59M | -18.12M | -11.45M | -9.4605 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Hcw Biologics Inc Borsa (HCWB) Ultime notizie
HCW Biologics Q2 net loss widens to $5.2M despite revenue surge - scanx.trade
Form 8K HCW Biologics Inc For: 14 August By Investing.com - Investing.com Nigeria
HCW Biologics Inc. Q2 2026: Revenue $135.6K, EPS $(11.58) — 10-Q Summary - TradingView
HCW Biologics Reports Second Quarter 2026 Financial Results and Updates HCW9302 Alopecia Areata Program, HCW11-018b Development and Financing Activities - Quiver Quantitative
HCW Biologics trial: 3 alopecia patients cut SALT scores 25%+ - Stock Titan
HCW Biologics Inc (HCWB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HCW Biologics (HCWB) completes $1.6M exempt equity and warrant sale - Stock Titan
HCW Biologics | D: Filing D - moomoo.com
HCWB Q2'26 Earnings: EPS estimate is (1.98) USD - TradingView
Price to earnings forward of HCW Biologics Inc. – NASDAQ:HCWB - TradingView
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Flowers Lee - moomoo.com
HCW Biologics Announces $1.6 Million Private Placement Financing - The Globe and Mail
HCW Biologics Raises $1.6 Million in Private Placement; Units Priced at $2.585 - TradingView
HCW Biologics Prices $1.6 Million Private Placement Offering - marketscreener.com
HCWB Looks 94.1% Undervalued on GF Value™ Amid Challenging Funda - GuruFocus
HCW Biologics prices $1.6M private placement offering By Investing.com - Investing.com Canada
HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering - GlobeNewswire
HCWB|HCW Biologics Inc|Price:2.640|Chg%:+0.140 - TradingKey
HCW Biologics Inc (HCWB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
HCW Biologics Inc (HCWB) Cash Flow - TradingKey
HCW Biologics (HCWB) Surges 6% as Shares Test Key Resistance Near $2.78Double EMA - dars.gov.et
HCW Biologics Inc (HCWB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
HCW Biologics Inc (HCWB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HCW Biologics Q1 2026 Earnings: Massive EPS Beat but Stock Plunges – Market Skepticism Over SustainabilityEPS Surprise History - dars.gov.et
TradingKey - TradingKey
HCWB|HCW Biologics Inc|Price:2.500|Chg%:-0.380 - TradingKey
HCW Biologics Inc (HCWB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
HCW Biologics Inc (HCWB) Valuation: PE, PB & Fair Value Analysis - TradingKey
HCW Biologics Inc. Revenue Breakdown – NASDAQ:HCWB - TradingView
HCW Biologics Inc. (HCWB) Stock Price, News, Quote & History - Yahoo! Finance Canada
HCW Biologics seeks pre-IND meeting with FDA for HCW-11-018b - BioWorld News
HCW Biologics Inc. (HCWB) stock price, news, quote and history - Yahoo Finance UK
HCW Biologics’ Cancer Candidate Targets Tissue Factor in Solid Tumors - Stock Titan
HCW Biologics requests FDA meeting for HCW11-018b solid tumor candidate - scanx.trade
HCWB Q1 2026 Earnings: Strong EPS Beat Despite Zero Revenue; Stock DeclinesManagement Tone Analysis - dars.gov.et
HCW Biologics Q1 2026 Earnings: Positive EPS Surprise Overwhelmed by Revenue AbsenceEarnings Beat Alert - dars.gov.et
HCW Biologics (HCWB) seeks $5.6M in stock sale to fund trials, repay debt - Stock Titan
HCWB Q1 2026 Earnings: EPS Surge on Non-Operating Items Overshadows Lack of RevenueBalance Sheet Strength - dars.gov.et
HCW Biologics Inc. Q1 2026 Earnings: Surprise EPS Beat Amidst No RevenuePre-Earnings Drift - DonanımHaber
HCW Biologics (HCWB) Declines 3.25% as Shares Approach Key Support LevelDealer Positioning - dars.gov.et
MSN Money - MSN
HCW Biologics (HCWB) Drops 8%: Testing Support Levels After Sharp DeclineSynthetic Long - dars.gov.et
HCW Biologics Regains Nasdaq Compliance, Plans Reverse Split - The Globe and Mail
HCW Biologics (HCWB) clears $2.8M disputes and $1.1M lien - Stock Titan
HCW Biologics Inc.: Top Mutual Funds Holders | QNCX | US40423R3030 - marketscreener.com
HCW Biologics Inc.: Fundamental Analysis and Financial Ratings | QNCX | US40423R3030 - marketscreener.com
HCW Biologics Inc.: Dividend historical data and projections - marketscreener.com
HCW Biologics regains Nasdaq compliance, plans stock split - Investing.com UK
HCW Biologics to Implement 1-for-6 Reverse Stock Split - Moomoo
HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter - Investing News Network
HCW Biologics regains Nasdaq compliance, plans stock split By Investing.com - Investing.com Nigeria
Hcw Biologics Inc Azioni (HCWB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):